Table 3 Univariate and multivariate analyses with respect to RFS in postmenopausal HR-positive/HER2-negative breast cancer treated for dyslipidemia

Age at diagnosis (>65)

1.034

0.324-3.882

0.957

BMI (>25.1)

1.383

0.423-4.548

0.584

Diabetes (negative)

1.348

0.398-6.115

0.649

Adjuvant chemotherapy (-)

1.196

0.264-4.044

0.793

Serum lipid level (preoperative) (Low, normal)

1.204

0.376-3.852

0.748

Tumor size (>2)

2.010

0.640-6.803

0.230

Lymph node (+)

1.862

0.549-5.854

0.302

NLR (preoperative) (High)

2.595

0.684-16.898

0.175

NLR (postoperative) (High)

2.573×10⁹

2.868-unparsable

0.002

2.087×10⁹

2.367-unparsable

0.992

Serum lipid control (Poor)

5.534

1.448-36.136

0.010

4.722

1.006-22.161

0.049

TILs (High)

2.229

0.608-8.153

0.218